Josh Waetzig

Person

Waltham, MA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H...
- Patent number 12,060,354
- Issue date Aug 13, 2024
- Blueprint Medicines Corporation
- Joshua D. Waetzig
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H...
- Patent number 11,999,744
- Issue date Jun 4, 2024
- Blueprint Medicines Corporation
- Joshua D. Waetzig
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H...
- Patent number 11,964,980
- Issue date Apr 23, 2024
- Blueprint Medicines Corporation
- Joshua D. Waetzig
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Citrate salt, pharmaceutical compositions, and methods of making an...
- Patent number 11,767,330
- Issue date Sep 26, 2023
- Foghorn Therapeutics Inc.
- Chong-Hui Gu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Process for the synthesis of 2-[(2S)-1-azabicyclo[2.2.2]oct-2-yl]-6...
- Patent number 11,524,957
- Issue date Dec 13, 2022
- Takeda Pharmaceutical Company Limited
- Lei Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Inhibitors of activin receptor-like kinase
- Patent number 10,669,277
- Issue date Jun 2, 2020
- Blueprint Medicines Corporation
- Kevin J. Wilson
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
STABILITY-ENHANCING COMPOSITIONS AND METHODS OF PREPARING COMPOUNDS
- Publication number 20250085300
- Publication date Mar 13, 2025
- Foghorn Therapeutics Inc.
- Liyue HUANG
- G01 - MEASURING TESTING
Information Patent Application
PROCESS FOR PREPARING EGFR INHIBITORS
- Publication number 20240300922
- Publication date Sep 12, 2024
- BLUEPRINT MEDICINES CORPORATION
- Erika Butler
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CITRATE SALT, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF MAKING AN...
- Publication number 20240190894
- Publication date Jun 13, 2024
- Foghorn Therapeutics Inc.
- Chong-Hui GU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE FORMS OF (S)-1-(4-FLUOROPHENYL)-1-(2-(4-(6-(1- METHYL-...
- Publication number 20240132510
- Publication date Apr 25, 2024
- BLUEPRINT MEDICINES CORPORATION
- Joshua D. Waetzig
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHOD OF PREPARING PRALSETINIB
- Publication number 20240059672
- Publication date Feb 22, 2024
- BLUEPRINT MEDICINES CORPORATION
- Joshua Waetzig
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SOLID FORMS OF PRALSETINIB
- Publication number 20230295121
- Publication date Sep 21, 2023
- BLUEPRINT MEDICINES CORPORATION
- Joshua Waetzig
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE FORMS OF (S)-1-(4-FLUOROPHENYL)-1-(2-(4-(6-(1-METHYL-1H...
- Publication number 20230271971
- Publication date Aug 31, 2023
- BLUEPRINT MEDICINES CORPORATION
- Joshua D. Waetzig
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PRALSETINIB PHARMACEUTICAL COMPOSITIONS
- Publication number 20230203009
- Publication date Jun 29, 2023
- BLUEPRINT MEDICINES CORPORATION
- Joshua Waetzig
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CITRATE SALT, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF MAKING AN...
- Publication number 20230064136
- Publication date Mar 2, 2023
- Foghorn Therapeutics Inc.
- Chong-Hui GU
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE
- Publication number 20220315585
- Publication date Oct 6, 2022
- BLUEPRINT MEDICINES CORPORATION
- Natasja Brooijmans
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SALT AND CRYSTAL FORMS OF AN ACTIVIN RECEPTOR-LIKE KINASE INHIBITOR
- Publication number 20220281879
- Publication date Sep 8, 2022
- BLUEPRINT MEDICINES CORPORATION
- Clare Medendorp
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRYSTALLINE FORMS OF (S)-1-(4-FLUOROPHENYL)-1-(2-(4-(6-(1-METHYL-1H...
- Publication number 20210147433
- Publication date May 20, 2021
- BLUEPRINT MEDICINES CORPORATION
- Joshua D. Waetzig
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PROCESS FOR THE SYNTHESIS OF 2-[(2S)-1-AZABICYCLO[2.2.2]OCT-2-YL]-6...
- Publication number 20210101897
- Publication date Apr 8, 2021
- Takeda Pharmaceutical Company Limited
- Lei Zhu
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE
- Publication number 20200031830
- Publication date Jan 30, 2020
- BLUEPRINT MEDICINES CORPORATION
- Kevin J. Wilson
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE
- Publication number 20170298069
- Publication date Oct 19, 2017
- BLUEPRINT MEDICINES CORPORATION
- Natasja Brooijmans
- C07 - ORGANIC CHEMISTRY

Josh Waetzig

Person

Patents Grantslast 30 patents

Crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H...

Crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H...

Crystalline forms of (S)-1-(4-fluorophenyl)-1-(2-(4-(6-(1-methyl-1H...

Citrate salt, pharmaceutical compositions, and methods of making an...

Process for the synthesis of 2-[(2S)-1-azabicyclo[2.2.2]oct-2-yl]-6...

Inhibitors of activin receptor-like kinase

Patents Applicationslast 30 patents

STABILITY-ENHANCING COMPOSITIONS AND METHODS OF PREPARING COMPOUNDS

PROCESS FOR PREPARING EGFR INHIBITORS

CITRATE SALT, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF MAKING AN...

CRYSTALLINE FORMS OF (S)-1-(4-FLUOROPHENYL)-1-(2-(4-(6-(1- METHYL-...

METHOD OF PREPARING PRALSETINIB

SOLID FORMS OF PRALSETINIB

CRYSTALLINE FORMS OF (S)-1-(4-FLUOROPHENYL)-1-(2-(4-(6-(1-METHYL-1H...

PRALSETINIB PHARMACEUTICAL COMPOSITIONS

CITRATE SALT, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF MAKING AN...

INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE

SALT AND CRYSTAL FORMS OF AN ACTIVIN RECEPTOR-LIKE KINASE INHIBITOR

CRYSTALLINE FORMS OF (S)-1-(4-FLUOROPHENYL)-1-(2-(4-(6-(1-METHYL-1H...

PROCESS FOR THE SYNTHESIS OF 2-[(2S)-1-AZABICYCLO[2.2.2]OCT-2-YL]-6...

INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE

INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE